Kyobo 8 Special Purpose Acquisition Company (307280) - Total Liabilities
Based on the latest financial reports, Kyobo 8 Special Purpose Acquisition Company (307280) has total liabilities worth ₩9.21 Billion KRW (≈ $6.24 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 307280 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Kyobo 8 Special Purpose Acquisition Company - Total Liabilities Trend (2022–2025)
This chart illustrates how Kyobo 8 Special Purpose Acquisition Company's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Kyobo 8 Special Purpose Acquisition Comp's assets to evaluate the company's liquid asset resilience ratio.
Kyobo 8 Special Purpose Acquisition Company Competitors by Total Liabilities
The table below lists competitors of Kyobo 8 Special Purpose Acquisition Company ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Izostal SA
WAR:IZS
|
Poland | zł332.02 Million |
|
PetMed Express Inc
NASDAQ:PETS
|
USA | $52.25 Million |
|
Alpha Exploration Ltd
V:ALEX
|
Canada | CA$395.82K |
|
Klondike Gold Corp
V:KG
|
Canada | CA$179.72K |
|
Highest Performances Holdings Inc.
NASDAQ:HPH
|
USA | $1.64 Billion |
|
Hamilton Global Opportunities PLC
PA:ALHGO
|
France | €5.46 Million |
|
Chembond Chemicals Ltd
NSE:CHEMBOND
|
India | Rs524.79 Million |
|
Scienjoy Holding Corp
NASDAQ:SJ
|
USA | $172.60 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down Kyobo 8 Special Purpose Acquisition Company's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Kyobo 8 Special Purpose Acquisition Comp.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kyobo 8 Special Purpose Acquisition Company's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kyobo 8 Special Purpose Acquisition Company (2022–2025)
The table below shows the annual total liabilities of Kyobo 8 Special Purpose Acquisition Company from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩5.00 Billion ≈ $3.39 Million |
+24.99% |
| 2024-12-31 | ₩4.00 Billion ≈ $2.71 Million |
-61.07% |
| 2023-12-31 | ₩10.28 Billion ≈ $6.97 Million |
-15.10% |
| 2022-12-31 | ₩12.11 Billion ≈ $8.20 Million |
-- |
About Kyobo 8 Special Purpose Acquisition Company
Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more